FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

No narrative content found in resource

Source1

{
  "id": "551ef667-1402-4c92-ba34-a0bb88b998dc",
  "resourceType": "Immunization",
  "extension": [
    {
      "url": "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "1324691000000104",
            "display": "Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine"
          }
        ]
      }
    }
  ],
  "identifier": [
    {
      "system": "https://tools.ietf.org/html/rfc4122",
      "value": "7ec28d82-33bf-4e6d-a8de-91dcbc8d1802"
    }
  ],
  "status": "completed",
  "primarySource": false,
  "reportOrigin": {
    "text": "RR8 - LEEDS TEACHING HOSPITALS NHS TRUST"
  },
  "occurrenceDateTime": "2021-02-23T13:00:08.476+00:00",
  "patient": {
    "reference": "Patient/1953684",
    "type": "Patient",
    "identifier": {
      "system": "https://fhir.nhs.uk/Id/nhs-number",
      "value": "9912003888"
    }
  },
  "vaccineCode": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "39114911000001105",
        "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
      }
    ]
  },
  "manufacturer": {
    "display": "DREAMLAND Pharmaceuticals Ltd"
  },
  "lotNumber": "R04X",
  "protocolApplied": [
    {
      "doseNumberPositiveInt": 2
    }
  ]
}